| Iridex Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/26 |
16:05 |
| CEA Industries Provides Update on Status of Renegotiation of Asset Management Agreement with 10X Capital |
Globe Newswire |
03/26 |
16:05 |
| IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results |
Globe Newswire |
03/26 |
16:05 |
| VirTra Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/26 |
16:05 |
| INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
03/26 |
16:05 |
| Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates |
Globe Newswire |
03/26 |
16:05 |
| CTO Realty Growth Announces First Quarter 2026 Earnings Release and Conference Call Information |
Globe Newswire |
03/26 |
16:05 |
| Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information |
Globe Newswire |
03/26 |
16:05 |
| Rapid7 Acquires Kenzo Security to Accelerate Preemptive, AI-Powered Security Operations |
Globe Newswire |
03/26 |
16:05 |
| TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2025 Financial Results on March 31, 2026 |
Globe Newswire |
03/26 |
16:05 |
| Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update |
Globe Newswire |
03/26 |
16:05 |
| Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly |
Globe Newswire |
03/26 |
16:05 |
| SKYX Reports Another Record Quarter with Revenue of $25 Million in Q-4 Demonstrating 8 Consecutive Quarters of Year Over Year Growth with Annual Record Revenue of $92 Million in 2025 Compared to $86 Million in 2024 as it Continues to Grow its Market Penetration |
Globe Newswire |
03/26 |
16:05 |
| SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update |
Globe Newswire |
03/26 |
16:05 |
| Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights |
Globe Newswire |
03/26 |
16:05 |
| LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update |
Globe Newswire |
03/26 |
16:05 |
| Aquafil to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026 |
Globe Newswire |
03/26 |
16:05 |
| CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/26 |
16:05 |
| Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO |
Globe Newswire |
03/26 |
16:05 |
| BLINK CHARGING ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS |
Globe Newswire |
03/26 |
16:02 |
| Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/26 |
16:02 |
| Galapagos Announces Nomination of Gino Santini to its Board of Directors |
Globe Newswire |
03/26 |
16:02 |
| Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/26 |
16:01 |
| Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million |
Globe Newswire |
03/26 |
16:01 |
| Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings |
Globe Newswire |
03/26 |
16:01 |
